Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 13Withdrawn 4Unknown 4Terminated 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 2Neoplasm Metastasis 2Colorectal Neoplasms 2Uveal Melanoma 1Sarcoma 1Pancreatic Neoplasms 1Neurofibromatosis 2 1Myeloproliferative Disorders 1Multiple Myeloma 1Macular Degeneration 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Colorectal Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Irinotecan 58Bevacizumab 56Oxaliplatin 49Leucovorin 49Fluorouracil 49Capecitabine 45Cetuximab 44pembrolizumab 23IFL protocol 15Nivolumab 11regorafenib 10Panitumumab 10Celecoxib 8Radiotherapy 7Cyclophosphamide 7atezolizumab 6Surgical Procedures, Operative 6Gemcitabine 6Folfox protocol 6Colonoscopy 6trifluridine tipiracil drug combination 5Neoadjuvant Therapy 5Metformin 5Immunohistochemistry 5Biopsy 5tislelizumab 4spartalizumab 4durvalumab 4Trastuzumab 4Mitomycin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Colorectal Neoplasms × aflibercept × Clear all
NCT01669720 2020-02-17

C261

Brown University

Phase 2 Terminated
10 enrolled 7 charts
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02045030 2016-11-16

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

CR-CSSS Champlain-Charles-Le Moyne

Phase 2 Terminated
14 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡